CompletedPhase 2NCT00039377
Chemotherapy, Imatinib Mesylate, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Studying Acute lymphoblastic leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Cancer Institute (NCI)
- Principal Investigator
- Meir WetzlerCancer and Leukemia Group B
- Intervention
- imatinib mesylate(drug)
- Enrollment
- 58 target
- Eligibility
- 15-59 years · All sexes
- Timeline
- 2002 – 2014
Study locations (30)
- Blood and Marrow Transplant Group of Georgia, Atlanta, Georgia, United States
- Saint Joseph Medical Center, Bloomington, Illinois, United States
- Graham Hospital Association, Canton, Illinois, United States
- Memorial Hospital, Carthage, Illinois, United States
- University of Chicago, Chicago, Illinois, United States
- Weiss Memorial Hospital, Chicago, Illinois, United States
- Eureka Hospital, Eureka, Illinois, United States
- Galesburg Cottage Hospital, Galesburg, Illinois, United States
- Illinois CancerCare Galesburg, Galesburg, Illinois, United States
- Mason District Hospital, Havana, Illinois, United States
- Hopedale Medical Complex - Hospital, Hopedale, Illinois, United States
- Mcdonough District Hospital, Macomb, Illinois, United States
- Loyola University Medical Center, Maywood, Illinois, United States
- Bromenn Regional Medical Center, Normal, Illinois, United States
- Community Cancer Center Foundation, Normal, Illinois, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00039377 on ClinicalTrials.govOther trials for Acute lymphoblastic leukemia
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT05621291A Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymphoblastic Leu...National Cancer Institute (NCI)
- ENROLLING BY INVITATIONNCT07511959Autologous Exosomes From Platelet-rich Plasma as a Modern Tool of Regenerative DentistryWroclaw Medical University
- RECRUITINGPHASE2NCT06738368Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic LeukemiaUniversity of Washington
- RECRUITINGNANCT07191119Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic LeukemiaSt. Jude Children's Research Hospital
- RECRUITINGNANCT07177183Low Serum Creatinine as a Predictor of Prolonged Mechanical Ventilation and Weaning FailureUniversity Hospital Ostrava
- RECRUITINGPHASE2NCT07275762Y-4 to Treat the Postherpetic NeuralgiaNeurodawn Pharmaceutical Co., Ltd.
- RECRUITINGNANCT07201974Virtual Reality for Post-Stroke Gait RehabilitationMcGill University
- ENROLLING BY INVITATIONNCT07515430The Association Between Gut Microbiome Composition Signature and Cancer-related Symptoms in Children With Acute Lymphoblastic LeukemiaSun Yat-sen University